NewAmsterdam Pharma Company N.V. revenue breakdown overview

NewAmsterdam Pharma Company N.V. revenue for the last year amounted to 45.60 M USD, the most of which — 45.56 M USD — came from its highest performing source at the moment, Transformative Therapies for Cardio-metabolic Diseases, the year earlier bringing 14.09 M USD. The greatest contribution to the revenue figure was made by Italy — last year it brought NewAmsterdam Pharma Company N.V. 45.56 M USD, and the year before that — 14.09 M USD.